Spelling suggestions: "subject:"cohort studies."" "subject:"kohort studies.""
61 |
Avaliação prospectiva de sintomas urinários em pacientes submetidos a radioterapia de pelve: infecção urinária ou cistite actínica / Prospective evaluation of urinary symptoms in patients submitted to pelvic radiotherapy: urinary infection or actinic cystitisXavier, Vitor Fonseca 02 April 2018 (has links)
A incidência de infecção do trato urinário (ITU) em pacientes submetidos a radioterapia pélvica com sintomas de cistite varia entre 6% e 45%. O diagnóstico de ITU é tipicamente realizado através dos sintomas de cistite associados à leucocitúria. Não há evidências para essa abordagem em indivíduos submetidos a radioterapia na pelve, pois essa população pode apresentar sintomas de cistite secundários ao câncer ou ao seu tratamento. O objetivo deste estudo foi avaliar a incidência de ITU em pacientes com sintomas de cistite submetidos à radioterapia pélvica. Realizou-se um estudo de coorte prospectivo cujos critérios de inclusão foram pacientes maiores de 18 anos, com câncer primário pélvico, tratados com intuito curativo e bom estado de performance. Foram excluídos pacientes em tratamento para ITU, usuários de cateteres urinários, pacientes em diálise, com cistostomia ou nefrostomia e uso de antibiótico durante o tratamento. O recrutamento ocorreu antes do início da radioterapia, realizou-se exame de urina tipo I e urocultura. Após o início do tratamento, foram realizadas consultas com avaliação semanal dos sintomas urinários segundo critérios do Radiation Therapy Oncology Group (RTOG). Em caso de aparecimento de novos sintomas urinários ou piora daqueles já existentes, aplicava-se questionário e colhia-se um segundo exame de urina tipo I e urocultura. O diagnóstico de ITU foi definido por urocultura com crescimento bacteriano maior que 104 CFU/mL. Entre setembro de 2014 e novembro de 2015 foram recrutados sequencialmente 112 pacientes. Destes, 29 (26%) não realizaram o primeiro exame. Entre os que realizaram o exame, 11 (10%) apresentaram urocultura positiva e foram excluídos. Restaram 72 (64%) pacientes no estudo. No seguimento destes, 24 (33%) pacientes apresentaram sintomas urinários novos ou piora dos sintomas pré-existentes. Apenas um (1,4%) paciente apresentou confirmação de ITU na segunda urocultura. Observamos uma incidência de ITU menor que a esperada. Isso pode ser explicado pela realização de urocultura pré-tratamento e exclusão dos pacientes com o exame positivo. Além disso, foi realizada investigação urinária apenas em pacientes sintomáticos. Esse controle da população estudada sugere que os dados da literatura relacionados à frequência de ITU até então sejam, na verdade, relacionados a pacientes com bacteriúria assintomática que desenvolveram sintomas devido à radioterapia. Dessa forma, concluímos que nosso achado é clinicamente muito relevante, pois através de uma avaliação prospectiva e controlada, encontramos uma incidência de ITU bem menor que a estimada até então pela literatura / The incidence of urinary tract infection (UTI) in patients undergoing pelvic radiotherapy with symptoms of cystitis varies from 6% to 45% and the diagnosis of UTI is typically made through the symptoms of cystitis associated with leukocyturia, findings that allow the use of antibiotics. However, there are no evidences for this approach in individuals undergoing pelvic radiotherapy, since this population may present symptoms of cystitis secondary to cancer or its treatment. The objective of the present study was to evaluate the incidence of UTI in patients with symptoms of cystitis submitted to pelvic radiotherapy and to identify correlated predictive factors. This was a prospective cohort study. Inclusion criteria were patients older than 18 years, with primary pelvic cancer in treatment with curative intent and good performance status. Exclusion criteria, patients being treated for UTI, use of urinary catheter, patients in dialysis, or with cystostomy or nephrostomy, and use of antibiotics during treatment. Patients were recruited before the beginning of radiotherapy, when urinalysis and urine culture were collected. After start of treatment, weekly consultations were performed with evaluation of urinary symptoms according to the Radiation Therapy Oncology Group (RTOG) scale. In case of new urinary symptoms or worsening of those already existing, a questionnaire was applied to analyze possible risk factors for UTIs and a second urinalysis and urine culture were performed. The diagnosis of UTI was defined as urine culture with a bacterial growth greater than 104 CFU / mL. From September 2014 to November 2015, 112 patients were sequentially recruited. Of these, 29 (26%) did not perform the first exam. Among those who underwent the test, 11 (10%) presented the first urine culture positive and were excluded, remaining 72 (64%) patients for the study. In the follow-up, 24 (33%) patients presented new urinary symptoms or worsened of pre-existing symptoms. In only one (1.4%) patient UTI was confirmed in the second urine culture. The incidence of UTI was lower than expected in this population. This can be explained by the performance of the pre-treatment evaluation with urine culture with exclusion of patients with positive exam. In addition, a urinary investigation was performed only in symptomatic patients. This control of the population studied suggests that the literature data related to the frequency of UTI so far may be related to patients with asymptomatic bacteriuria who developed symptoms due to radiotherapy. Thus, we conclude that our finding is clinically very relevant, since through a prospective and controlled evaluation, an incidence of UTI much lower than that estimated so far in the literature was detected
|
62 |
Efetividade de interferon peguilado e ribavirina no tratamento da hepatite C crônica em pacientes atendidos em um centro universitário no Estado de São Paulo / Effectiveness of pegylated interferon and ribavirin for the treatment of chronic hepatitis C among patients treated at a reference center in São Paulo stateAline Vitali Grando 23 June 2016 (has links)
Introdução: Informações de vida real relativas ao tratamento da hepatite C crônica com interferon peguilado (Peg-IFN) e ribavirina (RBV) servem para mensurar sua efetividade nos anos em que o seu uso foi amplamente difundido, além de auxiliar em tomada de decisões futuras. Objetivos: Avaliar a taxa de resposta virológica sustentada (RVS) nos pacientes com hepatite C crônica tratados com Peg-IFN e RBV, fora de protocolos de pesquisa. Determinar os fatores associados à obtenção de RVS, frequência e causas de interrupção precoce do tratamento e de redução ou interrupção temporária dos medicamentos. Métodos: Estudo observacional retrospectivo de uma coorte de pacientes de dois ambulatórios de um centro de referência brasileiro localizado em São Paulo/SP. Resultados: Dos 440 indivíduos analisados, 182 apresentaram RVS (prevalência: 41,4% [IC95%: 36,7 - 46,1]). A RVS ocorreu em 33,5% (104/310) dos pacientes com genótipo 1 e em 53,8% (7/13) e 60,5% (69/114) daqueles com genótipos 2 e 3, respectivamente. Após análise multivariada, a RVS esteve positiva e independentemente associada à presença dos genótipos 2 ou 3 (p < 0,001), ausência de esteatose (p = 0,025) e de tratamento prévio (p = 0,038). Os eventos adversos mais frequentemente relacionados à redução de dose ou suspensão temporária de Peg-IFN ou RBV foram anemia (15,6%) e plaquetopenia (3,9%). Dos eventos adversos que levaram 79 (18%) pacientes a interromper o tratamento precocemente, distúrbios psiquiátricos (15,1%) e anemia (13,9%) foram os mais frequentes. Conclusões: A taxa de RVS foi semelhante àquela obtida em outros estudos de vida real. A RVS esteve independentemente associada à: presença dos genótipos 2 ou 3, ausência de esteatose e ausência de tratamento prévio. As principais causas de redução de dose dos medicamentos foram anemia e plaquetopenia e de interrupção precoce do tratamento, desordens psiquiátricas, e citopenias / Introduction: The association of pegylated interferon (Peg-IFN) and ribavirin (RBV) was considered a first line treatment for chronic hepatitis C during the past decade. Routine clinical practice information and real-life treatment outcomes can guide future therapeutic strategies for this group of patients. Objectives: The main objective of our study was to determine the sustained virological response (SVR) rate under current clinical practice. The secondary objectives were: 1- to investigate the factors that before or during treatment could predict SVR 2- to identify the causes of treatment interruption. Method: This cross-sectional study enrolled hepatitis C patients treated with Peg-IFN and RBV in a tertiary outpatient clinic setting. Data were collected retrospectively on patients treated for hepatitis C. Demographics, treatment outcomes and potential predictors of outcome were recorded. Results: Among the 440 analyzed patients 182 achieved SVR (prevalence: 41.4% [95% CI: 36.7 to 46.1]). On an intention-to-treat basis, SVR rates were 33.5% (104/310), 53.8% (7/13) and 60.5% (69/114) in genotypes 1, 2 and 3 respectively. After multivariate analysis, SVR was independently associated with presence of genotypes 2 or 3 (p < 0.001), no hepatic steatosis (p=0.025) and absence of prior treatment (p = 0.038). Anemia (15.6%) and thrombocytopenia (3.9%) were the most frequent causes of treatment dose reduction. Among the adverse events that led 79 patients into treatment discontinuation, the most frequent were psychiatric complications (15.1%) and anemia (13.9%). Conclusion: In our cohort, the treatment success rate (SVR) was similar to that observed in other in real-life setting studies. The SVR was independently associated with: presence of genotypes 2 or 3, no hepatic steatosis and absence of prior treatment. Psychiatric disorders and anemia were the main causes of premature treatment discontinuation
|
63 |
Hipertensão intracraniana na meningoencefalite criptocócica em pacientes soropositivos para o vírus da imunodeficiência humana: estudo de uma série de casos / Elevated intracranial pressure in HIV patients with cryptococcal meningoencephalitis: a case seriesNajara Maria Procópio Andrade 27 November 2006 (has links)
Os objetivos deste estudo foram: (1) Descrever e analisar as principais características da hipertensão intracraniana em pacientes com meningoencefalite criptocócica e aids; (2) Descrever e comparar as características clínicas, epidemiológicas, laboratoriais e evolutivas associadas à presença de hipertensão intracraniana em pacientes com meningoencefalite criptocócica e aids; (3) Identificar fatores associados à má evolução em pacientes com meningoencefalite criptocócica e aids. Este é um estudo de coorte prospectivo que avaliou 34 pacientes soropositivos para o HIV internados no Instituto de Infectologia Emílio Ribas no período de janeiro de 2003 a março de 2004. Definição de caso: paciente com sinais e sintomas de meningoencefalite com cultura de líquor positiva para Cryptococcus neoformans. Hipertensão intracraniana foi definida como pressão liquórica inicial >= 200 mmH2O. Todos os pacientes receberam tratamento inicial com anfotericina B e aqueles casos que apresentaram hipertensão intracraniana foram submetidos a um algoritmo específico de punções diárias de alívio ou shunt. Os pacientes foram analisados durante o período de internação. Vinte e seis pacientes eram do gênero masculino (76,5%); com média de idade de 35,4 anos; com imunodepressão grave (média de cels T CD4+ = 35,4 anos). Sete (20,6%) pacientes souberam do diagnóstico da infecção pelo HIV a partir da criptococose, que foi a primeira doença definidora de aids em 61,8% dos casos. Hemocultura foi positiva em 52,9% dos casos. Hipertensão intracraniana ocorreu em 20 (58,9%) pacientes à admissão e em 25 (73,52%) em qualquer momento da evolução clínica. Os fatores associados estatisticamente à ocorrência de hipertensão intracraniana foram: turvação visual (P=0,02), alteração de nervos cranianos (P=0,03), e número de células fungicas no LCR > 100 células/ mm3 à admissão (P=0,036). As punções diárias de alívio foram eficazes em controlar a hipertensão intracraniana em 21 (62%) casos e shunt foi realizado em seis casos. A mortalidade geral foi de 26,5%, porém na maioria dos casos a causa do óbito foi atribuída à infecção hospitalar. Os fatores estatisticamente associados à evolução para óbito foram: hipertensão arterial sistêmica (P=0,048), coma (P=0,048), déficit motor (P=0,014) e número elevado de células fúngicas no líquido cefalorraquidiano (P=0,030). / The objectives of this study were: (1) To describe and analyze the main characteristics associated to elevated intracranial pressure in patients with Cryptococcal meningoencephalitis and aids. (2) To describe and to compare clinical, epidemiologic, laboratorial and outcome characteristics associated to elevated intracranial pressure in patients with Cryptococcal meningoencephalitis and aids (3) To identify associated factors to poor outcome in patients with Cryptococcal meningoencephalitis and aids This is a prospective cohort study that analyzed 34 HIV infected patients hospitalized at Emilio Ribas Institute during the period of January 2003 to March 2004. Case definition: Patients with clinical manifestations of meningoencephalitis and isolation of Cryptococcus neoformans from Cerebrospinal Fluid. Elevated intracranial pressure was defined as cerebrospinal fluid opening pressure >= 200 mmH2O. All patients were initially treated with amphotericin B and that who presented with elevated intracranial pressure were submitted to a specific algorithm of repeated lumbar drainage or shunt. The patients were followed during hospitalization period. Results: Twenty six patients were male (76.5%); with mean of age of 35, 4 years. The means of T CD4 count was 28,5 cell/ . Cryptococcosis led to diagnosis of HIV infection in 20,6% of patients, whereas it was the aids-defining disease in 61,8% of patients. Blood cultures were positive in 52,9% of cases. Elevated intracranial pressure was presented in 20 (58,9%) patients at admission, and in 25 patients (73,52%) during evolution. Elevated intracranial pressure was associated to visual turvation (P=0,02), cranial nerve abnormalities (P=0,03) and number of fungal cells ³ 100 cells/ mm3 at admission (P=0,036). Lumbar puncture was efficient to control elevated intracranial pressure in 21 (62%) cases and six patients were submitted to shunt. Overall mortality was 26,5%. Factors associated to death were: arterial hypertension (P=0,048), coma (P=0,048), motor deficits (P=0,014) and raised number of fungal cells in cerebrospinal fluid at admission (P=0,03).
|
64 |
Urticária crônica espontânea em pacientes com lúpus eritematoso sistêmico juvenil / Chronic spontaneous urticaria in juvenile systemic lupus erythematosus patientsMariana Paes Leme Ferriani 23 May 2016 (has links)
Introdução: Estudos avaliando a prevalência de urticária crônica espontânea (UCE) no lúpus eritematoso sistêmico juvenil (LESJ), assim como possíveis fatores associados são restritos a poucos relatos de caso. Objetivos: Avaliar a prevalência de UCE em uma população expressiva de LESJ, assim como sua possível associação com dados demográficos, manifestações clínicas, alterações laboratoriais, atividade/dano cumulativo da doença e tratamento. Métodos: Um estudo de coorte multicêntrico retrospectivo foi realizado em 10 serviços de Reumatologia Pediátrica provenientes do Grupo Brasileiro de Lúpus e incluiu 852 pacientes com LESJ. UCE foi diagnosticada de acordo com o guideline do EAACI/GA2LEN/EDF/WAO. Os pacientes foram divididos em dois grupos para a avaliação das manifestações clínicas atuais, assim como parâmetros laboratoriais e tratamento: pacientes que tiveram UCE (avaliados durante o diagnóstico da urticária) e pacientes sem UCE (avaliados na última consulta). Resultados: A presença de urticária foi observada em 10/852 (1,17%) pacientes com LESJ. A comparação entre os pacientes com LESJ com e sem UCE revelou uma maior frequência de sintomas constitucionais (40% vs. 8%, p=0,005), envolvimento do sistema reticuloendotelial (30% vs. 3%, p=0,003), sintomas mucocutâneos (90% vs. 28%, p < 0,0001), manifestações musculoesqueléticas (50% vs. 6%, p < 0,0001) e necessidade de pulso de metilprednisolona (60% vs. 8%, p < 0,0001) no grupo com UCE. A frequência do uso de imunossupressor foi menor nos pacientes com UCE (20% vs. 61%, p=0,017). As medianas do SLEDAI-2K (12 vs. 2, p < 0,0001) e do VHS (40 vs. 19 mm/1a hora, p=0,024), foram maiores nos pacientes com UCE. Conclusões: Este foi o primeiro estudo que evidenciou a possível relação da UCE com LESJ. A UCE aconteceu predominantemente no início do curso do LESJ e esteve associada com uma atividade de doença moderada/alta e sem envolvimento de órgãos nobres / Background: Data regarding the prevalence of chronic spontaneous urticaria (CSU) in childhood-onset systemic lupus erythematosus (cSLE) patients and possible associated factors are limited to few case reports. The objectives of the present study were to assess CSU in a large cSLE population evaluating demographic data, clinical manifestations, disease activity/damage, laboratory abnormalities and treatment. Methods: A retrospective multicenter cohort study (Brazilian cSLE group) was performed in 10 Pediatric Rheumatology services including 852 cSLE patients. CSU was diagnosed according to EAACI/GA2LEN/EDF/WAO Guidelines. Patients with CSU (evaluated at urticaria diagnosis) and patients without CSU (evaluated at last visit) were assessed for lupus clinical/laboratory features and treatment. Results: CSU was observed in 10/852 (1.17%) cSLE patients. Comparison of cSLE patients with and without CSU revealed a higher frequency of constitutional (40% vs. 8%, p=0.006), reticuloendothelial system involvement (30% vs. 3%, p=0.003), mucocutaneous (90% vs. 28%, p < 0.0001) and musculoskeletal manifestations (50% vs. 6%, p < 0.0001) and methylprednisolone pulse therapy use (60% vs. 8%, p < 0.0001) in the former group. The frequency of immunosuppressive treatment was lower in patients with CSU(p=0.017). The median SLEDAI-2K (12 vs. 2, p < 0.0001) and ESR (40 vs. 19 mm/1sthour, p=0.024), was higher in patients with CSU. Conclusions: To our knowledge this was the first study that evidenced that CSU may be linked to cSLE. We also demonstrated that this particular skin manifestation occurs predominantly at disease onset and it was associated with lupus moderate/high disease activity without major organ involvement
|
65 |
Procalcitonina (PCT) como indicador de infecção grave em adultos neutropênicos febris / Procalcitonin (PCT) as a marker of severe systemic infection in febrile neutropeniaKarin Schmidt Rodrigues Massaro 07 December 2007 (has links)
Introdução: Neutropenia febril é uma emergência médica que demanda um diagnóstico precoce e administração de antibióticos o mais breve possível. A procalcitonina (PCT) é um marcador inflamatório que vem sendo utilizado como um indicador de infecção bacteriana grave. A detecção precoce do quadro séptico é difícil, principalmente numa população heterogênea como no caso dos neutropênicos febris. A possibilidade de um único exame laboratorial poder identificar precocemente os quadros de sepse contribuiria de forma significativa para melhorar o prognóstico destes pacientes. Objetivo: Avaliar os níveis de PCT como marcador de infecção sistêmica comparados aos níveis de proteína C-reativa (PCR) em pacientes neutropênicos febris. Métodos: Foram estudadas amostras de 65 pacientes com a finalidade de determinar as concentrações séricas de PCT, PCR e outros parâmetros hematológicos em três momentos diferentes: antes da febre, no momento da febre e 72 após o término da febre. Os pacientes foram divididos inicialmente em quatro grupos: com infecção sistêmica comprovada laboratorial ou clinicamente (I), com febre de origem indeterminada - FOI- (II), com infecção localizada (III) e com infecção fúngica confirmada (IV). Posteriormente, os grupos I e IV foram denominados de 1 (com infecção sistêmica) e os grupos II e III de 2 (sem infecção sistêmica). Treze pacientes não apresentaram febre durante a internação sendo excluídos da comparação PCT/PCR. Resultados: A concentração de PCT mostrou estar associada com o diagnóstico de infecção grave e neutropenia febril. Não houve correlação entre os níveis de PCT e PCR. Conclusão: Fica evidente que a PCT demonstrou ser um marcador útil para o diagnóstico de infecção sistêmica em neutropenia febril, sendo provavelmente, superior à PCR. Pode-se caracterizar a PCT como um auxiliar de indicador de infecção sistêmica já no primeiro dia de apresentação da febre. A PCT, ao contrário da PCR, foi capaz de distinguir entre infecção sistêmica e infecção localizada ou febre de origem indeterminada, tendo boa capacidade diagnóstica. Entretanto, a PCT não se correlacionou com o prognóstico, possivelmente pelo pequeno tamanho da amostra, apesar da curva ROC da PCT do grupo com infecção sistêmica com evolução para óbito ter delimitado uma área estatisticamente diferente da esperada pelo acaso. / Introduction: Febrile neutropenia is a medical emergency that calls for a precocious diagnosis and the administration of antibiotics as soon as possible. The procalcitonin (PCT) is an inflammatory marker that has been used as an indicator of severe bacterial infection. Considering that neutropenic population is heterogeneous, an early and only reliable laboratory test that could identify septic patients would be of great value to improve its outcome. Objective: Assess the diagnostic value of PCT as a marker of systemic infection, comparing with C-reactive protein (CRP) levels in febrile neutropenia. Methods: Sixty-five adults patients were enrolled in the study. Blood sample was collected in order to determine the serum concentrations of PCT, CRP and other hematological parameters at three different moments: before the beginning of fever, at the onset of fever and 72 hours after cessation of it. Firstly, the patients were divided into four groups: with clinical or laboratorial proven systemic infection (I), with fever of undetermined origin (FUO) (II), with localized infection (III) and with proven fungal infection (IV). After that, the groups I and IV were named as 1:- with systemic infection. The groups II and III were named 2:- without systemic infection. Thirteen patients did not present fever during evolution and were excluded from the PCT/PCR comparison among febrile patients. Results: The PCT concentration showed it was associated with the diagnosis of severe infection in febrile neutropenia. No correlation could be found between the levels of PCT and CRP. Conclusion: PCT seems to be an useful marker for the diagnosis of systemic infection in febrile neutropenia, probably better than CRP. We could assume that PCT could indicate systemic infection at the very first day of the outcome of fever. Only PCT (and not CRP) could be able to distinguish between systemic infection and localized infection or FUO, with excellent diagnostic capacity. However none of the markers (PCT and CRP) could be correlated to prognosis, possibly due to the small size of the sample. Nevertheless, PCT ROC curve for evolution to death as a result of systemic infection limit an area under the curve statistically different that expected by chance.
|
66 |
Birth-characteristics, hospitalisations, and childbearing : Epidemiological studies based on Swedish register dataEkholm Selling, Katarina January 2007 (has links)
In the past decades there has been an improvement in the medical treatment of children born preterm or with reduced foetal growth. This has resulted in a much higher survival rate of these children, but also in a higher number of surviving children with chronic conditions. These changes have, in turn, increased interest in investigating the connection between birth-characteristics and outcomes in later life. The overall aim of the present thesis was to study the relations between birth-characteristics, subsequent hospitalisations, and childbearing by means of data available in Swedish population-based registries. The study population in this thesis consisted of women (and men in Paper III) born in 1973-75 according to the Medical Birth Register and the Total Population Register. Information available in other registries, such as the Hospital Discharge Register, was obtained by individual record linkage. In Paper I, 148,281 women, alive and living in Sweden at 13 years of age, were included. Of the women, 4.1% were born preterm and 5.4% were born small for gestational age, and approximately 30% of all women had given birth between 13 and 27 years of age. We found that reduced foetal growth and possibly preterm birth were related to the likelihood of giving birth during the study period. The intergenerational effects of preterm birth and reduced foetal growth were investigated in Paper II and the study population consisted of 38,720 mother-offspring pairs. An intergenerational effect of reduced foetal growth was found, and reduced foetal growth in the mother also increased the risk for preterm birth in the child. Paper III was concerned with 304,275 men and women living in Sweden at 13 years of age. Of these men and women, 30% were hospitalised during adolescence and early adulthood (i.e. between 12 and 23 years of age). We found that men and women born small for gestational age or preterm were more likely to be hospitalised, and that those born small for gestational age seemed to be more at risk compared to those born preterm. Finally, in Paper IV, the relation between hospitalisations during adolescence and the likelihood of giving birth was studied in 142,998 women living in Sweden at 20 years of age. We found that a majority of the causes of hospitalisation during adolescence were positively connected to the likelihood of giving birth between 20 and 27 years of age. The relations presented in Papers I-IV were evident although socio-economic characteristics were adjusted for.
|
67 |
Evidence that bipolar disorder is the poor outcome fraction of a common developmental phenotype: an 8-year cohort study in young peopleTijssen, Marijn J. A., Van Os, Jim, Wittchen, Hans-Ulrich, Lieb, Roselind, Beesdo, Katja, Mengelers, Ron, Krabbendam, Lydia, Wichers, Marieke 30 January 2013 (has links) (PDF)
Background: Reported rates of bipolar syndromes are highly variable between studies because of age differences, differences in diagnostic criteria, or restriction of sampling to clinical contacts.
Method: In 1395 adolescents aged 14–17 years, DSM-IV (hypo)manic episodes (manic and hypomanic episodes combined), use of mental health care, and five ordinal subcategories representing the underlying continuous score of (hypo)manic symptoms (‘mania symptom scale’) were measured at baseline and approximately 1.5, 4 and 10 years later using the Munich-Composite International Diagnostic Interview (DIA-X/M-CIDI).
Results: Incidence rates (IRs) of both (hypo)manic episodes and (hypo)manic symptoms (at least one DSM-IV core symptom) were far higher (714/105 person-years and 1720/105 person-years respectively) than traditional estimates. In addition, the risk of developing (hypo)manic episodes was very low after the age of 21 years [hazard ratio (HR) 0.031, 95% confidence interval (CI) 0.0050–0.19], independent of childhood disorders such as attention deficit hyperactivity disorder (ADHD). Most individuals with hypomanic and manic episodes were never in care (87% and 62% respectively) and not presenting co-morbid depressive episodes (69% and 60% respectively). The probability of mental health care increased linearly with the number of symptoms on the mania symptom scale. The incidence of the bipolar categories, in particular at the level of clinical morbidity, was strongly associated with previous childhood disorders and male sex.
Conclusions: This study showed, for the first time, that experiencing (hypo)manic symptoms is a common adolescent phenomenon that infrequently predicts mental health care use. The findings suggest that the onset of bipolar disorder can be elucidated by studying the pathway from non-pathological behavioural expression to dysfunction and need for care.
|
68 |
A developmental approach to depression in youth : examining the effect of child maltreatment, race and gender on the developmental trajectories of depressive symptoms /Orton, Heather Dyan. January 2008 (has links)
Thesis (Ph.D. in Epidemiology) -- University of Colorado Denver, 2008. / Typescript. Includes bibliographical references (leaves 103-109). Free to UCD Anschutz Medical Campus. Online version available via ProQuest Digital Dissertations;
|
69 |
The association of a history of breastfeeding and the risk of asthma in two year old childrenReese, Jessica Anne. January 2008 (has links) (PDF)
Thesis--University of Oklahoma. / Bibliography: leaves 70-75.
|
70 |
Infecção hospitalar no Centro de Tratamento Intensivo Geral de um hospital escola da Região Sul do BrasilBarbosa, Gilberto da Luz January 2002 (has links)
Objetivos Avaliamos a incidência de infecção hospitalar no CTI clínico-cirúrgico de um hospital escola no sul do Brasil. Foram utilizadas taxas ajustadas para o tempo de permanência dos pacientes e para o tempo de exposição aos procedimentos invasivos. Também investigamos a influência da causa básica de internação (trauma, neurológico e clínico-cirúrgico) nas taxas de infecções. Material e Métodos Os pacientes internados no CTI Clínico-cirúrgico de março a dezembro de 1999, foram prospectivamente seguidos para a detecção de infecção hospitalar. Para o diagnóstico de infecção hospitalar utilizou-se as definições do Centro de Controle e Prevenção de Doenças dos EUA (CDC) e as taxas foram calculadas de acordo com a metodologia NNIS (Sistema Nacional de Vigilância Epidemiológica). Resultados Foram acompanhados 686 pacientes (4201 pacientes-dia). Ocorreram 125 infecções hospitalares, sendo que a incidência global foi de 18,2% ou 29,8 infecções por 1000 pacientes-dia. Os sítios de infecção mais freqüente foram: pneumonia (40%), infecção urinária (24%) e septicemia primária (12,8%). As taxas de infecções hospitalares, associadas aos procedimentos invasivos, foram as seguintes: 32,2 pneumonias por 1000 ventiladores mecânico-dia, 9,7 infecções urinárias por 1000 sondas vesicais-dia e 7 septicemias por 1000 cateteres venosos centrais-dia. A incidência global de infecção nos pacientes com trauma (26,8) e neurológicos (20,7%) foi superior quando comparada com o grupo clínico-cirúrgico (12,2%), p < 0,001. Conclusões Encontramos altas taxas de infecções relacionadas com os procedimentos invasivos neste CTI. A causa básica de internação influenciou as taxas de infecção, sugerindo a necessidade de analisar-se estratificadamente os pacientes em CTI clínico-cirúrgico. / Objectives The incidence of nosocomial infections in the General ICU of the Hospital São Vicente de Paulo was evaluated using adjusted rates for patients’ lenght of stay and time of device exposure. We also determined the differences in the rates of infections according basic reason for admission (trauma, neurological, and medical-surgical). Material and Methods From March 1 to December 31 1999, patients in the General ICU were prospectively followed for detection of nosocomial infection during their stay. Diagnosis of nosocomial infection was made according to the Centers for Disease Control e Prevention (CDC) definitions and the rates were calculated according to the methods of the National Nosocomial Infections Surveillance (NNIS) System. Results Six hundred eighty-six patients (4,201 patient-days) were followed. One hundred twenty-five nosocomial infections occurred and the overall rate was 18.2% or 29.8 infections per 1,000 patient-days. The most commonly found infection sites were: pneumonia (40%), urinary tract infection (24%), and primary bloodstream infections (12.8%). Device-associated nosocomial infection rates were as follows: 32.2 pneumonias per 1,000 ventilator-days, 9.7 urinary infections per 1,000 indwelling urinary catheter-days, and 7 bloodstream infection per 1,000 central venous catheter-days. Overall incidence of infection in trauma (26.8) and neurological (20.7%) groups was higher than in the medical-surgical group (12.2%), p<0.001. Conclusions Our study found a high incidence of pneumonia and high rates of nosocomial infections associated with use of an invasive device in this ICU. The basic cause for admission affected infection rates, suggesting the need for a stratified analysis of patients in the General ICU by basic reason for admission.
|
Page generated in 0.0424 seconds